Russell Van Gelder, director of the University of Washington (UW) Medicine Eye Institute and chairman of the UW Department of Ophthalmology, will address innovations in eye disease research and rejuvenating vision from 1 p.m. to 2:30 p.m. Friday, April 21 at the Central Library, 1000 Fourth Ave., Level 1, Microsoft Auditorium, 206-386-4636 .

Library events are free and open to the public. Registration is not required. Parking is available in the Central Library garage at the regular rates.

Learn about groundbreaking advancements being made in research using stem cell therapy, gene therapy and drug therapy to treat blinding diseases like macular degeneration, glaucoma and diabetic retinopathy.

Van Gelder was born and raised in and around New York City. He graduated from Stanford University's M.D./Ph.D. program, earning his Ph.D. in neurosciences studying the molecular biology of circadian rhythms.  His research has been continuously funded by the NIH since 1999. His laboratory has been at the forefront of two fields, non-visual photoreception and pathogen detection in uveitis. Since 2008, Van Gelder has been the Boyd K. Bucey Memorial Chair, professor and chairman of the Department of Ophthalmology at the UW. He is director of the UW Medicine Eye Institute and is adjunct professor of biological structure and of pathology. Nationally, he is a trustee of the American Academy of Ophthalmology and serves as chairman of the council.